SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

BHEL, Wipro and Sun Pharma to see some action today

Amara Raja Energy & Mobility Ltd. | Batteries | Automobiles | BSE: 500008 | NSE: ARE&M

01 Sep 2021 Evaluate

Bharat Heavy Electricals (BHEL) has bagged an order worth Rs 10,800 crore from NPCIL for EPC of Turbine Island for 6 units of 700 MWe. The six orders, received on August 30, 2021, envisage setting up of four units of 700 MWe at Gorakhpur, Haryana, and two units of 700 MWe at Kaiga, Karnataka.

Wipro has partnered with HERE Technologies to offer location-based services, to customers from energy and utilities, manufacturing, transport and Logistics, telecom, and automotive industry verticals. An Internet of Things (IoT)-based smart metering solution being developed by both companies, will provide better information to customers on energy consumption and asset management.

Sun Pharmaceutical Industries has the exclusive right to commercialize Winlevi in the US and Canada. Cassiopea will be the exclusive supplier of the product, which is expected to be available in the US in the fourth quarter of 2021. The expiration of the applicable waiting period under the US Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) clears the path for making Winlevi available to patients and healthcare providers in the US and Canada.

Amara Raja Batteries has completed the acquisition of 11.36% stake in Log 9 Materials Scientific on August 30, 2021. The company’s investment is a part of the bold ‘Energy & Mobility’ strategy announced by the Company in June this year, which focuses on entering into new green technologies and solutions. These initiatives will include expansion and investment that will help the Company maintain technological and business leadership in the ‘Energy & Mobility’ space, apart from creating new growth avenues.

Shilpa Medicare has received Drugs Controller General of India (DCGI) approval for ‘2-Deoxy2-Glucose’ (Bulk & Oral Powder). The bulk is manufactured by Shilpa Medicare, API facility in Raichur,' Karnataka. The Oral Powder is manufactured by its subsidiary, Shilpa Therapeutics, facility in Hyderabad, Telangana. 2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients. The product will be available with a brand name '2-DGSHIL'.

TVS Srichakra has forayed into the Indonesian market, with the Eurogrip range of tyres, in its bid to strategically build a strong presence in the Southeast Asian nation. The first product line to be launched is ''Eurogrip Bee City'' – a range of two-wheeler tyres completely customized to suit the needs of Indonesian riders' urban lifestyle and road conditions.

Digispice Technologies’ subsidiary company -- Spice Money has entered into a joint venture with Tarya group, Israel’s leading fintech player with 70% P2P market-share in Israel, to bring Bharat to the fore of the ongoing data-led digital revolution by launching a lend-tech platform targeted towards rural India. The synergy between Tarya Fintech and Spice Money will lead to the creation of an innovative, agile, assisted and technologically superior digital lending platform.

Amara Raja Energy Share Price

778.45 5.80 (0.75%)

17-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
Exide Inds	330.05
Amara Raja Energy	778.45
HBL Engineering	786.60
Eveready Inds. India	302.45
Indo-National	326.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

BHEL, Wipro and Sun Pharma to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.